Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 12,140 | 10,775 | 8,441 | 7,090 | 6,809 |
| Operating Income | -12,140 | -10,775 | -8,441 | -7,090 | -6,809 |
| Other Income | 1,077 | 872 | 751 | 702 | 622 |
| Pre-tax Income | -11,063 | -9,903 | -7,690 | -6,388 | -6,187 |
| Net Income Continuous | -11,063 | -9,903 | -7,690 | -6,388 | -6,187 |
| Net Income | $-11,063 | $-9,903 | $-7,690 | $-6,388 | $-6,187 |
| EPS Basic Total Ops | -0.46 | -4.85 | -14.41 | -27.25 | -27.97 |
| EPS Basic Continuous Ops | -0.46 | -0.80 | -11.39 | -9.68 | -9.98 |
| EPS Diluted Total Ops | -0.46 | -4.85 | -14.41 | -27.25 | -27.97 |
| EPS Diluted Continuous Ops | -0.46 | -0.80 | -11.39 | -9.68 | -9.98 |
| EBITDA(a) | $-11,975 | $-10,640 | $-8,325 | $-6,975 | $-6,697 |